SynonymsBot
Synonyms for amphastar or Related words with amphastar
amphadase
hydase
primapharm
savient
vitrase
indevus
pharmacosmetics
halozyme
astellas
incimmunogen
abraxis
valeant
acetylon
abbvie
thallion
keryx
synta
biomarin
celltrion
sicor
predix
scios
santhera
ferring
vioquest
serostim
actelion
anthera
omrix
axcan
telik
progenics
incariad
incmgi
collagenex
alnylam
bionumerik
catalent
llcperifosine
genetech
tekmira
celldex
geltex
actavis
jagsonpal
calmactin
esperion
sepracor
cocarcinoma
idec
Examples of "amphastar"
Amphastar
has been criticized for its pricing of naloxone, a drug that treats opiod overdose.
Amphastar
Pharmaceuticals is a publicly traded American pharmaceutical company. Its products include Enoxaparin Sodium Injection, Cortrosyn, Amphadase, Emergency Syringes in Luer-Jet, Lidocaine, Naloxone, and Phytonadione Injection.
Brand names of animal-derived hyaluronidase include Hydase (developed and manufactured by PrimaPharm Inc., distributed by Akorn Inc.), which has been FDA-approved as a "thimerosal-free" animal-derived hyaluronidase, Vitrase (Bausch + Lomb/Valeant Pharmaceuticals), Amphadase (
Amphastar
Pharmaceuticals), and Wydase. Wydase, however, is no longer manufactured.
In January 2015, Lesser filed two bills regarding opioid abuse. Lesser's bills served as the blueprint for the plan ultimately adopted by the Massachusetts State Senate in its 2015 budget, which allocated $100,000 in state funds to buy doses of the drug Naloxone, commonly known as Narcan, which can reverse opiate overdoses. Later in 2015, Massachusetts Attorney General Maura Healey announced a settlement with
Amphastar
Pharmaceuticals, Inc., the manufacturer of naloxone, in which
Amphastar
paid $325,000 into the state's bulk purchasing program. The state's fund spent $377,000 to buy 11,050 doses of naloxone and 8,750 applicators; as of November 30, 2016, 8,500 doses have been distributed to cities and towns in Massachusetts, saving local communities an estimated $186,000.
Dr. Zasloff has served on several corporate boards, including
Amphastar
Pharmaceuticals, Inc. (Lead Independent Director, 2005–present), Biosynexus, Inc. (2005 - 2010), Enterin, Inc ( Chairman, 2015–present), Sarentis, Inc. (2016-present), Novo Biosciences (2013-present), and Formula XO, Inc. (Chairman, 2013–present). He also has served on the scientific advisory boards of Novozymes (2005-2008) and Dipexium Pharmaceuticals (2007–present), which was formerly known as Macrochem.
The city's favorable location and host of public amenities have earned it numerous distinctions. Notably, "Money" Magazine ranked Rancho Cucamonga 42nd on its "Best Places to Live" list in 2006. In addition, "Insider" Magazine established one Rancho Cucamonga neighborhood as the 13th richest neighborhood in Southern California. All of the city's four public high schools earned the "Silver" distinction in a 2015 ranking of the nation's high schools by "U.S. News & World Report". The city's proximity to major transportation hubs, airports, and highways has attracted the business of the nation's largest corporations including Coca-Cola, Nong Shim, Frito-Lay, and
Amphastar
Pharmaceuticals.